Search results
Results from the WOW.Com Content Network
The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. [1] The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm). The initial course ...
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI).
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF.
[167] [168] The vaccine is known as "COVID-19 Vaccine Moderna Intramuscular Injection". [169] [3] In May 2021, COVID‑19 Vaccine Moderna Intramuscular Injection (formerly TAK-919) was authorized for emergency use in Japan. [3] In June 2021, the Moderna COVID‑19 vaccine was authorized for use in India by the Drugs Controller General of India ...
This article documents the chronology and epidemiology of SARS-CoV-2 in 2019, the virus that causes coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 known to have been identified were in Wuhan , Hubei , China , in December 2019, which marked the beginning of the 2019–2020 COVID-19 ...
By late November 2019, coronavirus disease 2019 had broken out in Wuhan, China. [2]As reported in Clinical Infectious Diseases on November 30, 2020, 7,389 blood samples collected between December 13, 2019, and January 17, 2020, by the American Red Cross from normal donors in nine states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington and Wisconsin ...
The effects of COVID-19 lockdowns were subject of the first quantitative research on large-scale modal shifts and demand reduction in aviation. [150] It illustrated that a significant share of business travel is not necessary [ 151 ] and advanced or increased the adoption of various methods and technologies to mitigate air travel demand.
The COVID-19 pandemic [4] in Norway resulted in 1,512,647 [2] confirmed cases of COVID-19 and 5,732 [2] deaths. On 26 February 2020, the virus was confirmed to have spread to Norway . [ 5 ] The number of cases increased rapidly during the month of March, prompting a number of legal measures aiming to achieve physical distancing to be introduced ...